This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a Université Laval directory, so their publications, courses and email address may be missing. Find their university profile.
Latest funding
- $100,000
COVID-19 Variant Network - Innovative therapeutic approaches for the 2019-novel coronavirus
CIHR · 2021 · Principal investigator
COVID-19 Variant Network - Innovative therapeutic approaches for the 2019-novel coronavirus
Principal investigators: Boivin, Guy; Finzi, Andrés; Liang, Chen; Lin, Sheng-Xiang
Keywords: Antivirals; Combination; Coronavirus; Ferret; Hamster; Modeling; Polymerase; Repurposing; Synergy; Transcriptomic
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.